DE69910997D1 - Azabzyclische 5ht1 rezeptor liganden - Google Patents

Azabzyclische 5ht1 rezeptor liganden

Info

Publication number
DE69910997D1
DE69910997D1 DE69910997T DE69910997T DE69910997D1 DE 69910997 D1 DE69910997 D1 DE 69910997D1 DE 69910997 T DE69910997 T DE 69910997T DE 69910997 T DE69910997 T DE 69910997T DE 69910997 D1 DE69910997 D1 DE 69910997D1
Authority
DE
Germany
Prior art keywords
azabcyclic
receptor ligands
ligands
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69910997T
Other languages
English (en)
Other versions
DE69910997T2 (de
Inventor
Michael Bright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of DE69910997D1 publication Critical patent/DE69910997D1/de
Application granted granted Critical
Publication of DE69910997T2 publication Critical patent/DE69910997T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Luminescent Compositions (AREA)
DE69910997T 1998-04-09 1999-03-18 Azabzyclische 5ht1 rezeptor liganden Expired - Fee Related DE69910997T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8123798P 1998-04-09 1998-04-09
US81237P 1998-04-09
PCT/IB1999/000457 WO1999052907A1 (en) 1998-04-09 1999-03-18 Azabicyclic 5ht1 receptor ligands

Publications (2)

Publication Number Publication Date
DE69910997D1 true DE69910997D1 (de) 2003-10-09
DE69910997T2 DE69910997T2 (de) 2004-05-19

Family

ID=22162936

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69910997T Expired - Fee Related DE69910997T2 (de) 1998-04-09 1999-03-18 Azabzyclische 5ht1 rezeptor liganden

Country Status (41)

Country Link
US (2) US6525048B1 (de)
EP (1) EP1070065B1 (de)
JP (1) JP3496759B2 (de)
KR (1) KR100378931B1 (de)
CN (1) CN1117092C (de)
AP (1) AP1175A (de)
AR (1) AR015751A1 (de)
AT (1) ATE248838T1 (de)
AU (1) AU749254B2 (de)
BG (1) BG104915A (de)
BR (1) BR9909522A (de)
CA (1) CA2327782A1 (de)
CO (1) CO5080727A1 (de)
CZ (1) CZ20003684A3 (de)
DE (1) DE69910997T2 (de)
DK (1) DK1070065T3 (de)
DZ (1) DZ2756A1 (de)
EA (1) EA003400B1 (de)
ES (1) ES2204154T3 (de)
HK (1) HK1035719A1 (de)
HR (1) HRP20000653A2 (de)
HU (1) HUP0102400A3 (de)
ID (1) ID26086A (de)
IL (1) IL138629A0 (de)
IS (1) IS5641A (de)
MA (1) MA26619A1 (de)
MY (1) MY133390A (de)
NO (1) NO20005004L (de)
NZ (1) NZ507010A (de)
OA (1) OA11496A (de)
PA (1) PA8469101A1 (de)
PE (1) PE20000413A1 (de)
PL (1) PL343408A1 (de)
PT (1) PT1070065E (de)
SK (1) SK14782000A3 (de)
TN (1) TNSN99056A1 (de)
TR (1) TR200002932T2 (de)
TW (1) TW555758B (de)
WO (1) WO1999052907A1 (de)
YU (1) YU59400A (de)
ZA (1) ZA992596B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231833B1 (en) * 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
UA62015C2 (en) * 1998-12-28 2003-12-15 Pfizer Prod Inc Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants)
BR0014166A (pt) * 1999-09-03 2002-05-14 Lilly Co Eli Método de utilização de inibidores de reabsorção de serotonina seletivo de rápido ataque para tratamento de disfunção sexual
GB2362826A (en) * 2000-06-02 2001-12-05 Lilly Co Eli A pharmaceutical composition comprising a serotonin transport inhibitor and a serotonin recptor antagonist
US6855729B2 (en) * 2001-02-20 2005-02-15 Timothy G. Dinan Treatment of fibromyalgia and related fatigue syndromes using antagonists or partial agonists of 5HT1a receptors
OA13038A (en) * 2003-03-12 2006-11-10 Pfizer Prod Inc Pryridyloxymethyl and benzisoxazole azabicyclic derivatives.
CA2555172A1 (en) * 2004-01-29 2005-09-09 Pfizer Products Inc. Combinations of an atypical antipsychotic and an aminomethylpyridyloxymethyl/benzisoxazole azabicyclic derivatives for treating cns disorders
JP4559749B2 (ja) * 2004-02-16 2010-10-13 あすか製薬株式会社 ピペラジニルピリジン誘導体
AR048112A1 (es) * 2004-03-25 2006-03-29 Solvay Pharm Bv Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor
AR049478A1 (es) 2004-03-25 2006-08-09 Solvay Pharm Bv Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas.
CA2571555A1 (en) * 2004-06-22 2006-01-05 Pfizer Products Inc. Diazabicyclic histamine-3 receptor antagonists
EP2248524A3 (de) 2004-08-25 2011-03-09 Takeda Pharmaceutical Company Limited Mittel zur prävention/behandlung von stressbedingter harninkontinenz und vorsorgeuntersuchungsverfahren dafür
WO2006027692A2 (en) * 2004-09-10 2006-03-16 Pfizer Products Inc. Methods of treating cognitive disorders using pyridyloxymethyl and benzisoxazole azabicyclic derivatives
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106849A (en) * 1988-05-24 1992-04-21 American Home Products Corporation Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of various central nervous system disorders
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents
US5157034A (en) * 1991-02-27 1992-10-20 Pfizer Inc. Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
HUT71488A (en) * 1991-09-25 1995-11-28 Pfizer Process for the production of neuroleptic 2-substituted perhydro-1-h-pyrido[1,2a]pyrazines and pharmaceuticals compositions containing the same
US5262428A (en) * 1992-03-13 1993-11-16 Wake Forest University Biologically active tropane derivatives
DK0646116T3 (da) * 1992-06-16 1999-12-27 Pfizer Fremgangsmåde og mellemprodukter til fremstilling af bis-aza-bicycliske anxiolytiske midler
GB9410512D0 (en) * 1994-05-25 1994-07-13 Smithkline Beecham Plc Novel treatment
US5731307A (en) * 1994-09-30 1998-03-24 Pfizer, Inc. Neuroleptic 2,7-disubtituted perhydro-1h-pyrido 1, 2-A!pyrazines
US5614523A (en) * 1995-01-17 1997-03-25 Eli Lilly And Company Compounds having effects on serotonin-related systems

Also Published As

Publication number Publication date
MY133390A (en) 2007-11-30
ZA992596B (en) 2000-10-08
IL138629A0 (en) 2001-10-31
DK1070065T3 (da) 2003-11-24
CN1305477A (zh) 2001-07-25
AU749254B2 (en) 2002-06-20
HUP0102400A2 (hu) 2001-11-28
AU3268799A (en) 1999-11-01
JP3496759B2 (ja) 2004-02-16
BR9909522A (pt) 2000-12-19
TR200002932T2 (tr) 2001-01-22
EP1070065B1 (de) 2003-09-03
PE20000413A1 (es) 2000-05-25
CN1117092C (zh) 2003-08-06
AP1175A (en) 2003-06-04
YU59400A (sh) 2003-10-31
CZ20003684A3 (cs) 2002-03-13
AP9901502A0 (en) 1999-06-30
SK14782000A3 (sk) 2002-06-04
CA2327782A1 (en) 1999-10-21
OA11496A (en) 2004-05-14
BG104915A (en) 2001-07-31
MA26619A1 (fr) 2004-12-20
HK1035719A1 (en) 2001-12-07
HUP0102400A3 (en) 2002-10-28
KR100378931B1 (ko) 2003-04-07
ES2204154T3 (es) 2004-04-16
PA8469101A1 (es) 2000-09-29
CO5080727A1 (es) 2001-09-25
US6887905B2 (en) 2005-05-03
EA200000910A1 (ru) 2001-04-23
ATE248838T1 (de) 2003-09-15
TW555758B (en) 2003-10-01
DZ2756A1 (fr) 2003-09-15
EA003400B1 (ru) 2003-04-24
WO1999052907A1 (en) 1999-10-21
KR20010042527A (ko) 2001-05-25
PT1070065E (pt) 2003-12-31
NO20005004L (no) 2000-11-27
PL343408A1 (en) 2001-08-13
HRP20000653A2 (en) 2001-04-30
US20030181458A1 (en) 2003-09-25
TNSN99056A1 (fr) 2005-11-10
EP1070065A1 (de) 2001-01-24
IS5641A (is) 2000-09-26
ID26086A (id) 2000-11-23
JP2002511469A (ja) 2002-04-16
NZ507010A (en) 2003-05-30
NO20005004D0 (no) 2000-10-04
US6525048B1 (en) 2003-02-25
DE69910997T2 (de) 2004-05-19
AR015751A1 (es) 2001-05-16

Similar Documents

Publication Publication Date Title
LTPA2009006I1 (lt) Trombopoetino junginiai
ATE229954T1 (de) Betacarbolinverbindungen
ID28266A (id) Senyawa-senyawa amidin
DE59910140D1 (de) Gleitschalungsfertiger
FI4209U1 (fi) Uusia yhdisteitä
NO20011745L (no) Forbindelser
ID23168A (id) Reseptor anatagonis vitronektin
ID23458A (id) Bentuk sediaan nefazodon
NO981305D0 (no) Utblåsningssikring
NO993089D0 (no) Dypvanns-lÕringsinnretning
NO20005006L (no) Kalsilytiske forbindelser
ATE248838T1 (de) Azabzyclische 5ht1 rezeptor liganden
NO20006662D0 (no) Fluorfenylresin-forbindelser
DE69907647D1 (de) Plattenschieber
ID23196A (id) Gandaran untuk lampuflouresen
DE59910025D1 (de) Zusatzfunktionselemente
NO20010562D0 (no) Skraper
DE59903528D1 (de) Cyaninfarbstoffe
SE9800977D0 (sv) New compounds
SE9800512D0 (sv) New compounds
SE9803747D0 (sv) New compounds
SE9800509D0 (sv) New Compounds
SE9800508D0 (sv) New Compounds
SE9800510D0 (sv) New Compounds
SE9803746D0 (sv) New compounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee